一氧化氮
再灌注损伤
缺血
药理学
抗氧化剂
医学
氧化应激
氟伐他汀
沃特曼宁
化学
麻醉
内科学
细胞凋亡
生物化学
辛伐他汀
PI3K/AKT/mTOR通路
作者
Akira Matsuki,Akihiko Igawa,Takashi Nozawa,Teruo Nakadate,Norio Igarashi,Makoto Nonomura,Hiroshi Inoue
出处
期刊:Circulation journal
[Japanese Circulation Society]
日期:2006-12-01
卷期号:70 (12): 1643-1649
被引量:35
标识
DOI:10.1253/circj.70.1643
摘要
BACKGROUND: Three-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors (statins) are known to attenuate myocardial ischemia-reperfusion (IR) injury. Fluvastatin (FV) has a potent free radical scavenging action, but it is unclear whether the timing of FV administration could affect its cardioprotective effect or if the antioxidant property of FV might attenuate IR injury. METHODS AND RESULTS: IR was induced in rats by left coronary artery occlusion for 30 min followed by 24-h reperfusion. The rats were divided into 4 groups: oral FV group (10 mg/kg per day for 2 weeks before ischemia); iv, FV group (10 mg/kg) before ischemia; iv, FV group (10 mg/kg) before reperfusion; and control group. Oxidative stress was evaluated by myocardial 8-hydroxydeoxyguanosine (8-OHdG) content. The area at risk did not different among the 4 groups. Pretreatment with FV for 2 weeks significantly reduced the infarct size by 28% as compared with the control group, but FV administered just before ischemia or reperfusion did not. Myocardial 8-OHdG content was not affected by FV. The infarct-sparing effect of FV was completely abolished by N(omega)-nitro-l-arginine methyl ester or wortmannin. CONCLUSIONS: The present results indicate that pretreatment with FV, but not just before ischemia or reperfusion, attenuates IR injury primarily through the nitric oxide pathway, not through its antioxidant property.
科研通智能强力驱动
Strongly Powered by AbleSci AI